Foss AM - Search Results

1

A comparative analysis of cervical cancer prevention between Nigeria and Nordic countries that have experienced a decline in cervical cancer incidence.

Anyasi HI, Foss AM. Anyasi HI, et al. Among authors: foss am. Int Health. 2021 Jul 3;13(4):307-317. doi: 10.1093/inthealth/ihaa062. Int Health. 2021. PMID: 33000170 Free PMC article. Review.

2

Cervical cancer screening among HIV-infected women: an economic evaluation in a middle-income country.

Vanni T, Luz PM, Grinsztejn B, Veloso VG, Foss A, Mesa-Frias M, Legood R. Vanni T, et al. Int J Cancer. 2012 Jul 15;131(2):E96-104. doi: 10.1002/ijc.26472. Epub 2011 Nov 9. Int J Cancer. 2012. PMID: 21964797

3

Uncertainty in environmental health impact assessment: quantitative methods and perspectives.

Mesa-Frias M, Chalabi Z, Vanni T, Foss AM. Mesa-Frias M, et al. Among authors: foss am. Int J Environ Health Res. 2013;23(1):16-30. doi: 10.1080/09603123.2012.678002. Epub 2012 Apr 19. Int J Environ Health Res. 2013. PMID: 22515647 Review.

4

Assessing framing assumptions in quantitative health impact assessments: a housing intervention example.

Mesa-Frias M, Chalabi Z, Foss AM. Mesa-Frias M, et al. Among authors: foss am. Environ Int. 2013 Sep;59:133-40. doi: 10.1016/j.envint.2013.06.002. Epub 2013 Jun 24. Environ Int. 2013. PMID: 23807176 Free article.

5

Quantifying uncertainty in health impact assessment: a case-study example on indoor housing ventilation.

Mesa-Frias M, Chalabi Z, Foss AM. Mesa-Frias M, et al. Among authors: foss am. Environ Int. 2014 Jan;62:95-103. doi: 10.1016/j.envint.2013.10.007. Epub 2013 Nov 2. Environ Int. 2014. PMID: 24189198 Free article.

6

Economic modelling assessment of the HPV quadrivalent vaccine in Brazil: a dynamic individual-based approach.

Vanni T, Luz PM, Foss A, Mesa-Frias M, Legood R. Vanni T, et al. Vaccine. 2012 Jul 6;30(32):4866-71. doi: 10.1016/j.vaccine.2012.04.087. Epub 2012 May 28. Vaccine. 2012. PMID: 22652405

7

Is modelling complexity always needed? Insights from modelling PrEP introduction in South Africa.

Grant H, Foss AM, Watts C, Medley GF, Mukandavire Z. Grant H, et al. Among authors: foss am. J Public Health (Oxf). 2020 Nov 23;42(4):e551-e560. doi: 10.1093/pubmed/fdz178. J Public Health (Oxf). 2020. PMID: 32026942

8

Sexual violence and conflict in Africa: prevalence and potential impact on HIV incidence.

Watts CH, Foss AM, Hossain M, Zimmerman C, von Simson R, Klot J. Watts CH, et al. Among authors: foss am. Sex Transm Infect. 2010 Dec;86 Suppl 3:iii93-99. doi: 10.1136/sti.2010.044610. Epub 2010 Oct 23. Sex Transm Infect. 2010. PMID: 20972241

9

Cost-effectiveness evidence for HPV self-sampling could be improved by giving greater attention to vulnerable populations.

Humphreys E, Foss A, Legood R. Humphreys E, et al. Prev Med. 2020 Aug;137:106048. doi: 10.1016/j.ypmed.2020.106048. Prev Med. 2020. PMID: 32507287 No abstract available.

10

The cost-effectiveness of herpes simplex virus-2 suppressive therapy with daily aciclovir for delaying HIV disease progression among HIV-1-infected women in South Africa.

Vickerman P, Devine A, Foss AM, Delany-Moretlwe S, Mayaud P, Meyer-Rath G. Vickerman P, et al. Among authors: foss am. Sex Transm Dis. 2011 May;38(5):401-9. doi: 10.1097/OLQ.0b013e31820b8bc8. Sex Transm Dis. 2011. PMID: 21317689 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

72 results

Search Page

Filters